HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

Amundi's Holding History (CIK: 0001330387)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 2,824,000 Value ($000) $2,831 Avg Close — Range —
Q1 2025
Shares 324,000 Value ($000) $339 Avg Close — Range —
Q4 2024
Shares 324,000 Value ($000) $320 Avg Close — Range —
Q3 2024
Shares 324,000 Value ($000) $317 Avg Close — Range —
Q2 2024
Shares 2,102,000 Value ($000) $2,001 Avg Close — Range —
Q1 2024
Shares 2,302,000 Value ($000) $1,998 Avg Close — Range —
Q4 2023
Shares 2,302,000 Value ($000) $1,974 Avg Close — Range —
Q3 2023
Shares 2,302,000 Value ($000) $1,917 Avg Close — Range —
Q2 2023
Shares 1,902,000 Value ($000) $1,583 Avg Close — Range —
Q1 2023
Shares 1,902,000 Value ($000) $1,604 Avg Close — Range —
Q4 2022
Shares 2,123,000 Value ($000) $1,988 Avg Close — Range —
Q3 2022
Shares 2,870,000 Value ($000) $2,461 Avg Close — Range —
Q2 2022
Shares 1,492,000 Value ($000) $1,360 Avg Close — Range —